ライフサイエンスコーパス: microcapsule

1 hilic and hydrophobic cargos within a single microcapsule.

2 from two different locations within the same microcapsule.

3 sequestered within a permeable, charged-film microcapsule.

4 co-microcapsules than the oil released from microcapsules.

5 lyoxypropylenetriamine into hollow polymeric microcapsules.

6 ferric reducing power than did whey protein microcapsules.

7 f Saccharomyces boulardii within spray dried microcapsules.

8 and aid in the generation of multifunctional microcapsules.

9 its the survivability of S. boulardii within microcapsules.

10 e-glutamine degradable polylysine (A-GD-PLL) microcapsules.

11 oxidant molecules was observed in gum arabic microcapsules.

12 t for the elasticity and osmotic collapse of microcapsules.

13 mer shell in the form of aqueous dispersible microcapsules.

14 in we report a general route to programmable microcapsules.

15 better thermal stability of resistant starch microcapsules.

16 n minutes to form self-assembled, core-shell microcapsules.

17 nd diabetic NODs given sham surgery or empty microcapsules.

18 ) assay is encapsulated into polyelectrolyte microcapsules.

19 inst challenge afforded by spermine-alginate microcapsules.

20 s in yogurts protected using MTGase-mediated microcapsules.

21 oss-linking ability of laccase, or CaCl2, on microcapsules.

22 em as templates to fabricate polyelectrolyte microcapsules.

23 ructure than the lentil protein-maltodextrin microcapsules.

24 f small molecules and active biomolecules in microcapsules.

25 Regular-size (0.8-1.1 mm) or small microcapsules (0.5-0.7 mm) were produced by cross-linkin

26 The microcapsules (13-42mum) promoted protection against oil

27 rats receiving transplants with smaller-size microcapsules (48+/-8 days, n=8) or regular-size capsule

28 For these dual-loaded microcapsules, a programmable and sequential release of

29 However, TEM inspection of these microcapsules after an alcohol challenge revealed no evi

30 of droplet size distribution around 9 mum), microcapsules after spray drying and double emulsions af

31 hylene glycol) was introduced into rat islet microcapsules (alginate-poly[L-lysine]-alginate microcap

32 Uniform core-shell alginate microcapsules (AMCs), 60-300 mum in diameter, were fabri

33 ng ideas to provide new functionality to the microcapsule and nanocapsule is layer-by-layer depositio

34 The presence of the cell wall polymers microcapsule and teichoic acid was measured by both gas

35 The pattern of release of oil from the microcapsules and co-microcapsules was similar.

36 e report the development of phototriggerable microcapsules and demonstrate the concept of protection

37 The in-vitro digestibility of the co-microcapsules and microcapsules was studied in terms of

38 Due to the cell-like attributes of polymeric microcapsules and polymersomes, material systems are ava

39 y of encapsulated oil, microstructure of the microcapsules and protection of fatty acids, especially

40 roach for prolonging graft function of islet microcapsules and reducing the number of islets required

41 ution with the lowest particle size for both microcapsules and the corresponding emulsions after rehy

42 between the molecule localization inside the microcapsules and the reactivity against the specific re

43 the microcapsules (W) were evaluated for the microcapsules and two non-encapsulated systems: ethanoli

44 Conventional poly-l-lysine-cross-linked microcapsules and unencapsulated islets were included as

45 rocapsules (alginate-poly[L-lysine]-alginate microcapsule), and 500 suboptimal encapsulated islets we

46 Intracranially implanted DOX and TMZ microcapsules are compared with systemic administration

47 The light-responsive microcapsules are composed of photocleavable o-nitrobenz

48 e-modified DNA shells, and the pH-responsive microcapsules are made of a cytosine-rich layer cross-li

49 the autonomous repair of damaged materials, microcapsules are needed that release their contents in

50 The size and wall thickness of the microcapsules are precisely controlled.

51 Hollow composite microcapsules are prepared by the assembly of pre-formed

52 Polyelectrolyte complex microcapsules are prepared using a novel template- and s

53 The microcapsules are produced spontaneously by ultrasonical

54 ure while the alginate and chitosan/alginate microcapsules are spherical with a smooth surface.

55 The microcapsules are stable under typical industrial operat

56 The work supports the concept that microcapsules are superior to hydrogel systems or other

57 Although the microcapsules are too large to enter the cracks, their f

58 ior to homogenization led to block copolymer microcapsules, as expected.

59 ol) barium sulfate to create barium-alginate microcapsules (BaCaps) that contained hMSCs.

60 n of mechanical damage is achieved through a microcapsule-based polymeric material system.

61 tivity in intact synthetic and biodegradable microcapsules before and after cell delivery as well as

62 Human endostatin released from the microcapsules brought about a 67.2% inhibition of BCE pr

63 that intravenous administration of alpha2MG-microcapsules (but not empty microcapsules) promoted neu

64 ts osmotic stress, hence we generated hybrid microcapsules by mixing PEG and ALG (MicroMix) or by coa

65 The interior of the microcapsule can be loaded with water-soluble hydrophili

66 Moreover, the size selectivity of the microcapsules can be adjusted by changing the type of de

67 The microcapsules can be rendered visible during the first s

68 The interfacially assembled supramolecular microcapsules can benefit from the diversity of polymeri

69 We show that these microcapsules can find the cracks on a surface and selec

70 Due to their geometry and elasticity, these microcapsules can uniquely serve as quantitative mechani

71 S), and the third group consisted of control microcapsules (CM), with no cross-linking.

72 The all-polysaccharide based polyelectrolyte microcapsules combining copigmentation for anthocyanin e

73 Polymer microcapsules composed of liquid carbonate cores and hig

74 nt capacities of gum arabic and maltodextrin microcapsules containing antioxidant molecules (trolox,

75 le more rationale layer-by-layer assembly of microcapsules containing biologically active molecules f

76 ication of "photonic pigments" consisting of microcapsules containing dense amorphous packings of cor

77 nsport and simultaneously rupturing adjacent microcapsules containing gallium-indium liquid metal (to

78 brane emulsification (ME) enabled to produce microcapsules containing procyanidins.

79 tolerance tests and HbA1c levels, and intact microcapsules containing viable, insulin-positive porcin

80 Fish oil was loaded into the microcapsule core and protected with a shell composed of

81 GG microcapsules could be readily visualized with positive-

82 n of the membrane building blocks to produce microcapsules covered in a chemically distinct, dense ne

83 with laccase (MCL), the second group was the microcapsules cross-linked with divalent cationic CaCl2

84 The first group was the microcapsules cross-linked with laccase (MCL), the secon

85 The two microcapsule DEET formulations exhibited 36-40% higher c

86 rom the PLGA-GLN pellet resulted in A-GD-PLL microcapsule degradation and eventual PC12 cell death fo

87 These microcapsule devices provide a safe, reliable vehicle fo

88 ore effective than soluble alpha2MG or empty microcapsules (devoid of active protein).

89 demonstrate both sorting by size (of protein microcapsule drug delivery agents) and sorting by refrac

90 Decapeptyl microcapsules elevated serum LH in female rats, but decr

91 Possible mechanisms by which microcapsules enhance protection against rotavirus chall

92 We found that spermine-alginate microcapsules enhanced protection against challenge 16 w

93 ainst the test microorganisms compared to IN microcapsules, especially at concentrations of 100mg/mL.

94 The chitosan microcapsules exhibited the maximum release rate at pH 2

95 um release rate at pH 2.5 while the alginate microcapsules exhibited the maximum release rate at pH 6

96 ovine islets were immobilized in "composite" microcapsules fabricated from alginate and low-relative

97 We show that the design of the microcapsules facilitates the suppression of incoherent

98 In this approach, a flexible microcapsule filled with a solution of nanoparticles rol

99 encapsulated in alginate-poly L-lysine (PLL) microcapsules for long-term delivery of hES.

100 tudy was to produce and characterise xylitol microcapsules for use in foods, in order to prolong the

101 ops, which can then be used as templates for microcapsule formation.

102 We determined the capacity of microcapsules formed by the combination of sodium algina

103 Microcapsules, formed by employing these experimental co

104 ulations were studied: a previously reported microcapsule formulation (Formulation A); a newly-develo

105 rmulation (Formulation A); a newly-developed microcapsule formulation (Formulation B); and a non-enca

106 n of hierarchically structured organosilicon microcapsules from commercially available starting mater

107 Spray-dried microcapsules from double (DM) and multilayered (MM) fis

108 c resonance (TD-NMR) were applied to analyse microcapsules glass transition temperature (Tg).

109 Further, characterization results for microcapsule glucose sensors demonstrate their suitabili

110 The chitosan microcapsules had a brain-like structure while the algin

111 Whey protein microcapsules had comparably lower release rates but hig

112 During in vitro digestion, gum arabic microcapsules had high release rates of phenolics with h

113 mbly of metal-organic frameworks (MOFs) into microcapsules has attracted great interest because of th

114 ross species lines using these biodegradable microcapsules has the potential to expand dramatically t

115 The prepared MOF/CW microcapsules have excellent stability and enable the st

116 The resulting BCNU-loaded PLGA microcapsules have significantly higher drug encapsulati

117 Layer-by-layer assembled microcapsules have the potential to be versatile cell de

118 idics can be used to fabricate solid-shelled microcapsules having precisely controlled release behavi

119 s for the assembly of the shell of nano- and microcapsules holds great promise for the tailor-made de

120 ) was adopted to measure the permeability of microcapsules (hollow hydrogel spheres with diameter < 1

121 vered via sustained-release heparin-alginate microcapsules implanted in ischemic and viable but ungra

122 for one-step fabrication of polyelectrolyte microcapsules in aqueous conditions.

123 ver, we demonstrate the application of these microcapsules in encapsulation and release of proteins w

124 It was possible to apply the microcapsules in yogurt, without compromising the rheolo

125 r/antioxidant), and incorporate the obtained microcapsules into yogurt.

126 The formulation of these probiotics into microcapsules is an emerging method to reduce cell death

127 Although many techniques exist for preparing microcapsules, it is still challenging to fabricate them

128 g the o-nitrobenzyl phosphate-functionalized microcapsules, lambda = 365 nm, or subjecting the pH-res

129 lsions and the characteristics of CEO-loaded microcapsules like morphology, moisture, wettability, so

130 ending recent observations made with dextran-microcapsules loaded with alpha2MG in experimental sepsi

131 o assemble light-responsive or pH-responsive microcapsules loaded with different loads (tetramethylrh

132 is presented to optimize the formulation of microcapsules loaded with labile compounds.

133 ioluminescent enzyme luciferase in different microcapsule locations has on activity in intact synthet

134 Islet-containing smaller-size microcapsules made of high-M alginate were more stable a

135 Mice that received Hb-C-containing microcapsules maintained normoglycemia for at least 8 we

136 gered release of the liquid contents for the microcapsules may be achieved either in air or within a

137 rt by crosslinked hemoglobin (Hb-C) in islet microcapsules may promote transplanted graft function by

138 ffects of transplanting alginate (ALG)-based microcapsules (Micro) in the confined and well-vasculari

139 WPI-CMC stabilized microcapsules not only showed the highest procyanidin co

140 The microcapsules obtained were characterised in terms of pa

141 The polysaccharide microcapsule of Staphylococcus aureus has been reported

142 Solid co-microcapsules of omega-3 rich tuna oil and probiotic bac

143 on the physical and structural properties of microcapsules of pure carrot juice.

144 The microcapsules of xylitol showed desirable characteristic

145 Compared with nonfluorinated alginate microcapsules, PFOB fluorocapsules increased insulin sec

146 virus, microencapsulated reovirus, or empty microcapsules plus live virus.

147 We also examine the effect of microcapsule position on cell transfection with plasmid

148 The exclusion limit of the microcapsules prepared at 5-min reaction time was found

149 io (HR=1.38-1.44) values showed that all the microcapsules prepared correspond to the "poor" flowabil

150 The yogurt containing microcapsules, presented a pH range from 3.89 to 4.17 an

151 The microcapsules produced are extremely monodisperse in siz

152 hate-replete and phosphate-limiting media on microcapsule production.

153 We present a new type of microcapsule programmed with a tunable active release me

154 ion of alpha2MG-microcapsules (but not empty microcapsules) promoted neutrophil migration into perito

155 aled that the incorporation of Hb-C in islet microcapsules promotes graft function for a longer perio

156 Initially, emulsion and microcapsule properties as a function of oil (20%-30%),

157 aterials, allowing for fine control over the microcapsule properties.

158 coacervate microdroplets and protein-polymer microcapsules (proteinosomes) that interact via electros

159 The A-GD-PLL microcapsules provided a 3-D microenvironment for good s

160 Decapeptyl microcapsules reduced LHRH-R mRNA expression in male pit

161 Upon mechanical damage, ruptured microcapsules release a liquid indicator molecule.

162 In the simulations, signaling microcapsules release agonist particles, whereas target

163 es release agonist particles, whereas target microcapsules release antagonist particles and the perme

164 We have demonstrated that microcapsules released Lf in small intestine allowing 6.

165 m 39% to 85% for gum arabic and maltodextrin microcapsules, respectively, suggesting that this carote

166 Rehydrated gum arabic microcapsules retained more total ACNs but less ferric r

167 All wine microcapsules revealed significant activity against medi

168 anocarriers for hydrophobic molecules in the microcapsule shell.

169 to pH = 5.0, results in the cleavage of the microcapsule shells and the release of the loads.

170 These microcapsules show non-iridescent structural colors that

171 lrhodamine isothiocyanate-AG encapsulated in microcapsules showed 5 times greater specificity for bet

172 The lentil protein-maltodextrin-alginate microcapsules showed better oxidative stability and had

173 The empty microcapsules showed capacity to scavenge all the studie

174 The microcapsules showed high stability in gastric condition

175 r transform infrared (FT-IR) spectroscopy of microcapsules showed peaks in the region of 900-1300cm(-

176 ater activity, moisture and oil content, and microcapsule size distribution was investigated.

177 to trap a small hydrophilic molecule in the microcapsule skin as cargo.

178 aim of this work was to produce solid lipid microcapsules (SLMs) loaded with AA using microfluidic t

179 omitant increase in oil droplet diameter and microcapsule surface oil content, and a decrease in oil

180 Self-healing is achieved with a dual-microcapsule system utilizing epoxy-amine chemistry in a

181 We have designed a microcapsule system with controllable biodegradability w

182 anthocyanin retention during storage for all microcapsules tested.

183 acids was higher in the oil released from co-microcapsules than the oil released from microcapsules.

184 We describe a hydrogel-based microcapsule that breaks down at a rate that can be adju

185 This protocol details methods to create microcapsules that are visible by X-ray, ultrasound (US)

186 ical processing ensures allergen-free pollen microcapsules that can be loaded with vaccine antigens.

187 we develop models for a colony of synthetic microcapsules that communicate by producing and releasin

188 l modeling, we design colonies of biomimetic microcapsules that exploit chemical mechanisms to commun

189 cles with EDTA yields the stimuli-responsive microcapsules that include the respective loads.

190 The use of this approach to fabricate microcapsules that only release their contents when expo

191 tion time was found to be 100,000, while the microcapsules that were allowed to react with PLL for 20

192 Tocotrienol microcapsules (TM) were formed by firstly preparing Pick

193 e applied dextran-based layer-by-layer (LbL) microcapsules to deliver alpha-2-macroglobulin (alpha2MG

194 The findings support the concepts of using microcapsules to encapsulate CB assays for reversible an

195 by create adhesion gradients that propel the microcapsules to move.

196 da = 365 nm, or subjecting the pH-responsive microcapsules to pH = 5.0, results in the cleavage of th

197 Selective cytotoxicity of the DOX-D-loaded microcapsules toward cancer cells is demonstrated.

198 address the cytotoxicity of the DOX-D-loaded microcapsules toward MDA-MB-231 breast cancer cells and

199 unosuppression, but thus far islets in large microcapsules transplanted in the peritoneal cavity have

200 the permeability and biodegradability of the microcapsules used in the present system.

201 ing tocotrienols, which was then gelled into microcapsules using alginate and chitosan.

202 ferric reducing antioxidant activity of the microcapsules (W) were evaluated for the microcapsules a

203 f nanoparticles is made possible by the thin microcapsule wall (comparable to the diameter of the nan

204 The characterization data show that the microcapsule walls consist of amorphous, oligomeric poly

205 M) revealed that the internal surface of the microcapsule was honeycomb-like networks containing nonh

206 Production of microcapsule was unaffected by changes in the environmen

207 The permeability of tested microcapsules was modified by the reaction time with 0.0

208 release of oil from the microcapsules and co-microcapsules was similar.

209 ro digestibility of the co-microcapsules and microcapsules was studied in terms of survival of L. cas

210 ype 1, encapsulated in biodegradable aqueous microcapsules, was found to bypass maternal antibody pas

211 g time, TOTOX values of SDASO in MRP-derived microcapsules were 29-87% lower than that of the non-cro

212 and droplet size distribution of redispersed microcapsules were analyzed.

213 Alginate/poly(L-lysine)/alginate microcapsules were chosen as a column substrate.

214 n were preloaded in CaCO3 scaffold, and then microcapsules were created by coating the sacrificial Ca

215 of mice were sacrificed on subsequent days; microcapsules were evaluated by histology; peritoneal ce

216 The microcapsules were evaluated for particle size, accelera

217 The microcapsules were evaluated structurally with respect t

218 roperties and release characteristics of the microcapsules were evaluated.

219 The microcapsules were formed using two different microfluid

220 Multi-core microcapsules were formed when the mixed microencapsulat

221 The microcapsules were further classified into three sub-gro

222 The microcapsules were loaded with Cur up to about 55% w/w w

223 an macrophage phagocytosis: in both settings microcapsules were more effective than soluble alpha2MG

224 The effect of cross-linking agents on the microcapsules were more significant when the microcapsul

225 vels of anthocyanin losses in blueberry wine microcapsules were much greater: 19.9% (HP-beta-CD) and

226 The microcapsules were multinucleated, not very water-solubl

227 s showed that spherical nano-, submicro- and microcapsules were obtained through both techniques, alt

228 Light-rupturable, liquid-filled microcapsules were prepared by coencapsulation of carbon

229 Blueberry ACN microcapsules were prepared from two wall materials (whe

230 microcapsules were more significant when the microcapsules were produced by microfluidics.

231 The microcapsules were removed at 2, 6, and 20 weeks and exa

232 tivities of blackcurrant and chokeberry wine microcapsules were stable and remained unchanged during

233 The microcapsules were subsequently placed within a poly(eth

234 bited a SICA effect when the cPPA core-shell microcapsules were suspended in ion-containing acidic me

235 Significant amounts of Lf released from microcapsules were then absorbed into bloodstream and ac

236 al characteristics and microstructure of the microcapsules, were investigated.

237 d and encapsulated in alginate-poly-l-lysine microcapsules wherein the cells spontaneously coalesced

238 an efficient encapsulation of alpha2MG into microcapsules, which enhanced i) human leukocyte recruit

239 observations, we developed cPPA programmable microcapsules whose payload release rates depend on the

240 Microcapsules with 20% oil, 2% protein and 18% maltodext

241 Polymeric microcapsules with a light-absorbing dye incorporated in

242 ses microfluidic droplets to generate porous microcapsules with easily customizable functionality.

243 tions and geometrical characteristics of the microcapsules with exceptional precision.

244 This method creates core-shell microcapsules with polymeric shell walls composed of sel

245 We report microcapsules with shell walls bearing both Boc and Fmoc

246 e progress made so far of bringing nano- and microcapsules with shells of densely packed colloidal pa

247 owever, it remains a challenge to obtain MOF microcapsules with size selectivity at the molecular sca

248 ort materials to assemble MOF/cell wall (CW) microcapsules with size-selective permeability.

249 ic (GA) coacervates was optimized to produce microcapsules with superior oxidative stability compared

250 incorporation of carbon nanotubes endows the microcapsules with the ability to respond to an external

251 epresented the best wall material to produce microcapsules with the highest entrapment efficiency ( a

252 icles (PHMs) are thin-walled, hollow polymer microcapsules with tunable nanoporous shells.

253 crucial element for producing low-dispersity microcapsules with well-ordered surface spines, as the u

254 that received the conventional control islet microcapsule (without Hb-C) transplant showed graft fail